The Incidence of Lymphoma in Children in Gezira State During 2005-2014:A general Population-Based Study
Introduction: Lymphomas are the third most often diagnosed malignant neoplasm among children and adolescents. They constitute about 10-15% of childhood malignancies. We aimed to quantify incidence of Lymphomas (HD and NHD) in the Gezira State and their difference with gender and age.
Methods: The data was abstracted and classified accordingly to the third revision of the International Classification of Childhood Cancer. Age-standardised rates (ASR) for three 5-year age groups (0–4 years, 5–9 years and 10–14 years) calculated for males and females.
Results: The total number of children diagnosed with lymphoma was 140 patients. NHL forms 75/140(53%) and HD 65/140(46%). Incidence of NHL was 6.68/million. Males with NHL was 48/75 (64%) with an ASR of 5.71/million and females 27/75(36%) with ASR of 4.04/million and a ratio of 1.7:1. The most common age group of presentation of NHL in males was 5-9 years of age, while in females was from 10-14 years of age. Incidence of HD was 4.22/million. Males constituted about 40/65 (62%) with an ASR of 4.72/million, while females were 25/65(38%) with ASR of 3.72 and males to females ratio of 1.6:1. The common age of presentation of HD in both males and females was 5-9 years of age.
In conclusion: The results presented in this study were similar with international results and comparable with them. Implemented analytical studies to clarify the different types of haematological malignancies will help to choose the right treatment and better cure.
2. Faizan M, Anwar S, Khan S. Demographics and Outome in Paediatric Non-Hodgkin Lymphoma: Single Centre Experience at The Children Hospital Lahore, Pakistan. Journal of the College of Physicians and Surgeons--Pakistan: JCPSP. 2018;28(1):48-51.
3. Osman I, Mohamadani A, Mohamed Kheir S. Non-Hodgkin Lymphoma in Sudanese Children. Sudan Journal of Medical Sciences. 2014;9(1):31-8.
4. Haroun HM, Mahfouz MS, Elhaj AM. Patterns of childhood cancer in children admitted to the institute of nuclear medicine, molecular biology and oncology (INMO), Wad Medani, Gezira state. Journal of family & community medicine. 2006;13(2):71.
5. Hoffbrand A. Non-Hodgkin's lymphoma In: Essential Hematology. AV Hoffbrand, PAH Moss, and JE Pettit. Blackwell, Publisher, Massachusetts, USA; 2006.
6. Fritz A, Percy CL, Jack A, Shanmugaratnam K, Sobin L, Parkin DM, al. e. International Classification of Diseases for Oncology, third edition (ICD-O-3) Geneva: World Health Organization; 2000.
7. Steliarova‐Foucher E, Stiller C, Lacour B, Kaatsch P. International classification of childhood cancer. Cancer. 2005;103(7):1457-67.
8. IARC/IACR. Guidelines on Confidentiality in the Cancer Registry. IARC Internal Report No. 2004 / 03. IARC, Lyon. 2004.
9. Stefan C, Bray F, Ferlay J, Liu B, Parkin DM. Cancer of childhood in sub-Saharan Africa. ecancermedicalscience. 2017;11.
10. Steliarova-Foucher E, Colombet M, Ries L, Hesseling P, Moreno F, Shin HY, Stiller CA. International Incidence of Childhood Cancer, Volume III (electronic version). Lyon, France: International Agency for Research on Cancer. Available from: http://iicc.iarc.fr/results/, accessed [16/6/2018]. 2017.
11. Stiller C, Parkin D. International variations in the incidence of childhood renal tumours. British journal of cancer. 1990;62(6):1026.
12. Harrington DS, Ye Y, Weisenburger DD, Armitage JO, Pierson J, Bast M, Purtilo DT. Malignant lymphoma in Nebraska and Guangzhou, China: a comparative study. Human pathology. 1987;18(9):924-.Last الحمد لله